f.yildiz
TL2 · Bergen
Contributes reviews on supplier material. Based in Bergen.
Joined 2 February 2025 · last posted 9d
98 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 31 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #62 · Compounds › Repair & healing peptides · 19 Jul 2026 · 1 like Answering the question post #60 raises rather than the one it answers. Nothing in this subcategory is medical advice and several members here are describing experiments…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #27 · Sourcing › Regulatory · 16 Jul 2026 · 0 likes No notes. Posting so the count is not one.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #34 · Compounds › Retatrutide · 14 Jul 2026 · 3 likes Glucagon receptor agonist is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
How shortages have affected compounding permissions Replied, post #34 · Access › Shortages · 13 Jul 2026 · 2 likes What would change my mind on shortages is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
-
Journal club: what we got wrong in an earlier session Replied, post #78 · Evidence › Journal club · 13 Jul 2026 · 30 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. That is the…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #39 · Practice › Side effects · 9 Jul 2026 · 31 likes The bit of Muscle cramps that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Submitting a sample: the process end to end Replied, post #53 · Sourcing › Independent verification · 2 Jul 2026 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. Trying to state the submitting a sample position in a way that someone who…
-
Tracking a shortage from primary sources rather than rumour Replied, post #75 · Access › Shortages · 29 Jun 2026 · 4 likes Post #74 is the version of this I will quote in future. One addition. Tracking a shortage came up in a thread eighteen months ago and was answered well. I cannot find…
-
Tracking intake honestly when appetite is absent Replied, post #60 · Nutrition & Training › Protein & intake · 15 Jun 2026 · 0 likes The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more protein" ignores the actual constraint. It is worth checking…
-
Electrolyte supplements: which ones do anything Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 10 Jun 2026 · 7 likes This follows post #24 rather than contradicting it. Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #104 · Practice › Storage & stability · 9 Jun 2026 · 0 likes Light protection is easy and cheap. The original carton exists for a reason and a vial stored in it is protected without anybody having to think about it again.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #57 · Practice › Storage & stability · 2 Jun 2026 · 23 likes Second-hand on Mean kinetic temperature, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #44 · Safety › Contraindications · 20 May 2026 · 14 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
A comparison of home results against a laboratory result on the same vial — does this… Replied, post #4 · Analytics › Home & field testing · 10 May 2026 · 15 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #52 · Practice › Administration · 30 Apr 2026 · 6 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. A genuinely late dose: the labelling generally says that if the next dose is more…
-
A 40-week log with the measurement method stated — does this still hold? Replied, post #5 · Outcomes › Progress reports · 27 Apr 2026 · 1 like Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Why this subcategory is stricter about sourcing than most Replied, post #22 · Compounds › Secretagogues & GH axis · 25 Apr 2026 · 3 likes Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #51 · Sourcing › Logistics · 24 Apr 2026 · 13 likes This follows post #49 rather than contradicting it. Regional warehouse stock versus direct was covered in the wiki last year and the page has a review date on it, which…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #157 · Access › Pricing · 24 Apr 2026 · 10 likes I had written a reply contradicting post #153 and deleted it. Here is what survived. Nothing here is financial advice and none of it is a route to a transaction.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #105 · Practice › Reconstitution · 20 Apr 2026 · 1 like Confirming post #102 from a second method, which matters more than confirming it from a second person. The practical version of Foaming during reconstitution is three…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #25 · Practice › Reconstitution · 19 Apr 2026 · 0 likes I read post #21 twice before replying, because I had assumed the opposite. A 0.3 mL barrel has more space between graduations than a 1 mL barrel for the same volume,…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #30 · Evidence › Journal club · 15 Apr 2026 · 6 likes Building on post #27 rather than restating it. What I can speak to on SURMOUNT-4 and continuation versus withdrawal is narrow, so I will keep it narrow rather than…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #74 · Practice › Interactions · 4 Apr 2026 · 0 likes Confirming post #71 from a second method, which matters more than confirming it from a second person. Adding a null result on anaesthesia and elective surgery. I…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #112 · Clinical › Bloodwork · 27 Mar 2026 · 0 likes The second most useful thing it does is say clearly when the answer is to book the appointment. A weak preference rather than a position.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #3 · Practice › Dosing & titration · 14 Feb 2026 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #85 · Access › Pricing · 10 Feb 2026 · 0 likes Coming back to post #83, because the follow-up matters more than the original answer. List prices versus negotiated prices: the price a pharmaceutical company publishes…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #14 · Outcomes › Progress reports · 7 Feb 2026 · 0 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #34 · Start Here › Welcome · 23 Jan 2026 · 4 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Preprint servers and what screening they do Replied, post #30 · Evidence › Preprints · 20 Jan 2026 · 3 likes Picking up post #27: that is the part I would want checked first. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #51 · Sourcing › Regulatory · 19 Jan 2026 · 0 likes Post #50 is the version of this I will quote in future. One addition. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #86 · Practice › Interactions · 9 Jan 2026 · 0 likes On post #83 — agreed on the reasoning, with one qualification. On Warfarin and altered intake: the maintained page in the documentation commons covers the general case…
-
A partial dose because the pen emptied mid-injection Replied, post #35 · Practice › Administration · 8 Jan 2026 · 17 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #26 · Meta › Site feedback · 23 Dec 2025 · 10 likes This follows post #25 rather than contradicting it. I keep a log for topic list specifically because my memory of it turned out to be systematically wrong in one…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #4 · Practice › Storage & stability · 20 Dec 2025 · 0 likes Worth separating two things that the opening post runs together. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation…
-
Tracking a preprint to publication: a worked example Replied, post #114 · Evidence › Preprints · 11 Dec 2025 · 1 like Narrowing post #113, because the general version has more than one answer. Author track record is a weak signal and it is a signal. A group that has published carefully…
-
Persistent vomiting and the threshold for seeking help Replied, post #78 · Safety › Adverse events · 29 Nov 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #33 · Documentation › Doc review · 24 Nov 2025 · 27 likes One more thing on evidence digest that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Long-time reader, first-time poster Replied, post #19 · Lounge › Introductions · 17 Nov 2025 · 3 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Pen dose counters: what a click does and does not guarantee Replied, post #36 · Devices › Pens & autoinjectors · 14 Nov 2025 · 3 likes Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to leakage at the site. It is on the instruction leaflet and it is…
-
What a purity-only report leaves out Replied, post #86 · Sourcing › Independent verification · 14 Nov 2025 · 0 likes No notes. Posting so the count is not one.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #16 · Pharmacology › Pharmacokinetics · 9 Nov 2025 · 20 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #45 · Compounds › Oral incretins · 28 Oct 2025 · 0 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #89 · Start Here › Welcome · 21 Oct 2025 · 0 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Hypertension improvement and when medication needs revisiting Replied, post #64 · Clinical › Comorbidities · 16 Sep 2025 · 7 likes Taking post #61 at face value and following it one step further. Post-authorisation safety studies are the place where under-studied populations eventually appear, and…
-
Documentation that appears only after payment Replied, post #25 · Sourcing › Red flags · 15 Sep 2025 · 27 likes I changed my mind about documentation after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #18 · Data & Tools › Datasets · 7 Sep 2025 · 26 likes The thing about Aggregated purity results across four that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look,…
-
Thyroid function tests during substantial weight change Replied, post #49 · Clinical › Bloodwork · 2 Sep 2025 · 20 likes This follows post #48 rather than contradicting it. The honest answer on thyroid function tests during substantial is that it depends, and the useful part is the list…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #58 · Analytics › Home & field testing · 30 Aug 2025 · 11 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. That is what I would do.…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #14 · Practice › Storage & stability · 26 Aug 2025 · 31 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #9 · Sourcing › Vendor reports · 22 Aug 2025 · 0 likes Everything in post #7 holds. The case it does not cover is the one I have. Reports of ordinary results are more valuable than reports of remarkable ones, precisely…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #42 · Practice › Reconstitution · 15 Aug 2025 · 2 likes I think the decimal-point error question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #64 · Compounds › Secretagogues & GH axis · 14 Aug 2025 · 0 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #163 · Compounds › Tirzepatide · 12 Aug 2025 · 3 likes Where I would push back on the tirzepatide in type 2 diabetes consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Are there stupid questions here? A staff answer, at length Replied, post #57 · Start Here › Welcome · 10 Aug 2025 · 2 likes One small courtesy that makes a large difference: put the specific question in the title. It is the single thing that most changes how quickly you get a useful reply.…
-
Travel coolers and how long they really hold Replied, post #54 · Devices › Cold chain · 5 Aug 2025 · 0 likes Confirming post #51 from a second method, which matters more than confirming it from a second person. Travel with medication: carrying a vial across borders requires…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #15 · Sourcing › Red flags · 1 Aug 2025 · 20 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them. I would rather be precise about…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #22 · Pharmacology › Receptor biology · 1 Aug 2025 · 19 likes Picking up post #19: that is the part I would want checked first. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects…
-
Titles that describe the question, not the situation Replied, post #55 · Start Here › How to Ask · 24 Jul 2025 · 26 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #13 · Regional › European Union · 20 Jul 2025 · 0 likes Source for the Cross-border purchase rules within figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 0 likes Worth separating two things that post #21 runs together. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #55 · Compounds › Oral incretins · 28 Jun 2025 · 0 likes Everything in post #51 holds. The case it does not cover is the one I have. Trial adherence in an oral trial with strict administration requirements is genuinely worse…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #20 · Access › Insurance & coverage · 20 Jun 2025 · 0 likes A well-written denial is genuinely useful because it tells you exactly what to submit next. A vague one is the harder case. Posting it because the silence on this was…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #138 · Evidence › Journal club · 15 Jun 2025 · 4 likes An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second.
-
An emergency department visit, described afterwards Replied, post #31 · Safety › Adverse events · 15 Jun 2025 · 0 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. Genuine question rather than a rhetorical one: has anyone here actually observed…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #88 · Access › Insurance & coverage · 13 Jun 2025 · 4 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
A supplier that answers analytical questions with restated claims Replied, post #87 · Sourcing › Red flags · 31 May 2025 · 17 likes If you are new and reading this thread for the answer to supplier: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #25 · Compounds › Repair & healing peptides · 28 May 2025 · 18 likes I think the TB-500 and thymosin beta-4 question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Requesting a translation of an existing page Replied, post #20 · Documentation › Wiki requests · 23 May 2025 · 0 likes Post #18 describes the usual case. This is about the unusual one. Where an existing document nearly covers it, extending that one is usually better than starting a new…
-
Pregnancy as an absolute contraindication Replied, post #103 · Safety › Contraindications · 21 May 2025 · 0 likes Confirming post #102 from a second method, which matters more than confirming it from a second person. Asking a pharmacist to check a contraindication takes minutes and…
-
Follow-up: What other technical communities get right that we do not Replied, post #98 · Lounge › Off topic · 15 May 2025 · 6 likes Not a rules-free zone: the guidelines still apply. No contact details, no invitations to take a conversation off the site, no endorsements of other communities. Just a…
-
Publishing an inconvenient result: a case study Replied, post #17 · Sourcing › Independent verification · 8 May 2025 · 2 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #46 · Sourcing › Independent verification · 4 May 2025 · 16 likes Adding the measurement that post #43 says would settle it. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are…
-
Follow-up: Documentation that appears only after payment Replied, post #40 · Sourcing › Red flags · 2 May 2025 · 31 likes Taking post #38 at face value and following it one step further. Since Documentation keeps coming up, it should probably be a maintained page rather than a recurring…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #26 · Clinical › Comorbidities · 1 May 2025 · 9 likes Cardiovascular risk looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Follow-up: Documentation that appears only after payment Replied, post #2 · Sourcing › Red flags · 15 Apr 2025 · 3 likes Coming back to the opening post, because the follow-up matters more than the original answer. Where somebody posts a concern, ask what would resolve it before arguing…
-
Scheduled maintenance and what will be unavailable Replied, post #92 · Meta › Announcements · 31 Mar 2025 · 4 likes I had written a reply contradicting post #88 and deleted it. Here is what survived. Two things can be true about scheduled maintenance at once: the mechanism is…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #130 · Compounds › Semaglutide · 17 Mar 2025 · 6 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #39 · Compounds › Tirzepatide · 14 Mar 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Why plausible mechanism is not evidence of effect Started this topic · Compounds › Repair & healing peptides · 8 Mar 2025 · 23 likes Asking directly, because I could not find a straight answer: Why plausible mechanism is not evidence of effect What changes if the standard account of plausible…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #156 · Sourcing › Regulatory · 6 Mar 2025 · 5 likes Building on post #155 rather than restating it. Pharmaceutical compounding rules looks different depending on whether you are reading the primary literature or the…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #116 · Sourcing › Regulatory · 4 Mar 2025 · 27 likes Adding a small correction to the pharmaceutical compounding rules summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
-
Assessing a warm arrival: the decision process Started this topic · Sourcing › Logistics · 6 Feb 2025 · 15 likes Posting this under the heading it deserves: Assessing a warm arrival: the decision process Everything below is what sits behind that. A question about assessing a warm…
-
What we do not know about retatrutide, listed explicitly Replied, post #73 · Compounds › Retatrutide · 28 Jan 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #68 · Compounds › Other compounds · 20 Jan 2025 · 6 likes Confirming post #67 from a second method, which matters more than confirming it from a second person. Adding the boring version of Research-use-only status, because the…
-
Fixed versus detachable needles: the trade-offs Replied, post #121 · Devices › Syringes & needles · 18 Jan 2025 · 0 likes Post #120 describes the usual case. This is about the unusual one. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to…
-
Building a sensible monitoring schedule with your prescriber Replied, post #27 · Clinical › Bloodwork · 19 Dec 2024 · 3 likes Adding a small correction to the building a sensible monitoring schedule summary above rather than a disagreement with it. The substance holds; one of the figures is…
-
Two sessions a week versus four: what the evidence supports Replied, post #32 · Nutrition & Training › Resistance training · 12 Dec 2024 · 9 likes The arithmetic in post #29 is right; the assumption feeding it is the part to check. The reports here that state the programme, the load and the timeframe are useful.…
-
Why "any advice?" is the least effective ending for a post Replied, post #94 · Start Here › How to Ask · 1 Dec 2024 · 30 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it.
-
Revisiting: Moderation log format change Replied, post #21 · Meta › Announcements · 9 Nov 2024 · 12 likes Reading the changed pages: the diff is smaller than the announcement implies, which is reassuring rather than disappointing. A large change to a documentation page…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #127 · Clinical › Comorbidities · 29 Oct 2024 · 14 likes Agreed on Hypertension improvement, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
-
Requesting a page: what makes a good request — what changed since Replied, post #124 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes Confirming post #123 from a second method, which matters more than confirming it from a second person. Format suggestions: if you think a maintained page could be…
-
Progressive overload when the scale is falling — one year on Replied, post #15 · Nutrition & Training › Resistance training · 30 Aug 2024 · 3 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose.
-
Correlation in a self-tracked dataset: what it can support Replied, post #27 · Research Methods › Statistics · 21 Aug 2024 · 3 likes Bayesian and frequentist analyses answer different questions and both are legitimate. What matters is that the reader knows which is on offer. I have left out the parts…
-
Reading a meta-analysis you disagree with, fairly Replied, post #9 · Evidence › Meta-analyses · 6 Aug 2024 · 0 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
The mass-error checker and its intended scope Replied, post #142 · Data & Tools › Calculators · 21 Jul 2024 · 7 likes Worth separating two things that post #139 runs together. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…
-
Pen wastage and its effect on real cost Replied, post #3 · Access › Pricing · 22 Jun 2024 · 10 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
Assessing a warm arrival: the decision process — one year on Replied, post #136 · Sourcing › Logistics · 2 Jun 2024 · 29 likes Assessing a warm arrival is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.